Functional foods, also known as nutraceuticals, are foods or food supplements designed to deliver a specific health benefit. The presentation will summarize the be claimed that the nutriceutical can prevent or cure heart disease.
Historically, the FDA was originally authorized to approve and regulate any substance making disease-related claims. Compounds not eligible for approval as drugs were severely restricted in the type of health-related claims that could be made. However, in recent years, additional legislation has modified the regulatory process for nutraceuticals.
The Nutritional Labeling and Education Act (1990) permitted companies to make health claims on food labels if the FDA determines that claims are supported by "significant scientific agreement".
Subsequently, the Dietary Supplement Health and Education Act (1994) established limits to intervention by the FDA specifically to situations arising from unsafe or toxic products. In this legislation, structure/function claims were defined and were limited to description of functions and/or effects of the substance in the body (and not on the disease).
Considerable current efforts are being expended to liberalize these regulatory requirements. Pending and proposed legislation focuses on other ways of making scientific or clinical data available to the public. Since these proposed approaches are generally designed to bypass FDA oversight and permit less rigorously regulated claims, many are controversial and it is not clear what modifications will actually emerge.
However, due to the increasingly high cost of drug research and development as well as the need to establish a basis of exclusivity and profitability for nutraceuticals if they are to be marketed successfully, these efforts are bound to continue.
Efforts will also continue to differentiate and define properties of individual nutraceuticals so that unique and potentially patentable properties can be identified. Biotechnology approaches may help in these efforts by developing novel production methods and enhancement of existing and transferred properties. Examples of these approaches and strategies will be discussed.
The marketing of herbal and plant products in the United States can be compared with that of nutraceuticals. The latter substances generally are supported by more scientific data, whereas the former are based upon traditional usage and custom. Herbal and plant products are generally accepted as safe by regulatory authorities if there is a history of use or other evidence of safety in the recommended use. In their labeling, they are permitted to (a) claim benefits related to a classical nutrient-deficiency disease prevalent in the United States, (b) describe a role in affecting structure and function in humans, (c) describe a documented mechanism by which an ingredient acts on structure or function, and (d) describe the general well being resulting from consumption. Manufacturing standards for herbal and plant products can be set by the FDA. Since these preparations are usually mixtures, purification and standardization of active ingredients as well as standardization of the preparation present particular problems.
The marketing of herbal and plant products in the United States also differs significantly from the process in Europe.
In Germany, particularly, many herbal and plant products have been licensed based upon published information and are sold and prescribed as reimbursable drugs with corresponding labels and package inserts. As public interest in alternative medicine continues to increase in the United States, some of the approaches used in this field in Europe may prove of value not only for herbal and plant products but also for nutraceuticals. Current and potential regulations of functional foods (nutraceuticals) will be discussed with emphasis on those features differentiating nutraceuticals from drugs. Current practices in nutraceutical development and limitations on their marketing and acceptance will be summarized.
Comparisons between development and marketing strategies used for herbal and plant products and those used for nutraceuticals will be outlined. Finally, conclusions will be derived concerning the status and evolving future prospects for nutraceuticals in the United States.
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